verified SJR 19,027 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Cell Press

workspace_premium Q1 — Cell Biology visibility_off Single blind Peer Review lock_open Open Access

Cancer Cell

Cancer Cell is a journal indexed in SJR in Cell Biology and Oncology with an H index of 416. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 4704 €. The scope of the journal is focused on Cancer, Cancer Cell, Cancer Biology. It has an SJR impact factor of 19,027 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 19,027.

Cancer Cell focuses its scope in these topics and keywords: cancer, signaling, breast, myeloid, cell, transformation, target, shock, epigenetic, protein, ...

ISSN: 1535-6108

Publisher: Cell Press

Category: Cell Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

19,027 Q1

H-index 416

Acceptance rate pie_chart

16% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.704 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

19,027

H-index

416

Docs (year)

190

Docs 3y

575

Total refs

11020

Cites 3y

14069

Citable 3y

381

Cites/Doc 2y

24.69

Ref/Doc

58.0

Immediate OA

4704 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

BRAF as a potential therapeutic target in melanoma and other malignancies

Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1

Considering the cancer consequences of altered DNA polymerase function

Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer

ChIP-ping Away at EWS/ETS Transcription Networks

Cesar Milstein: October 8, 1927-March 24, 2002

Cell cycle progression without cyclin E/CDK2

Cdk2 dethroned as master of S phase entry

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

Building through Breaking: The Development of Cancer Neochromosomes

SHOW MORE ARTICLES

Breast cancer susceptibility - A new look at an old model

(Re-)Engineering tumor cell-selective replicating adenoviruses: A step in the right direction toward systemic therapy for metastatic disease

BLIMP1 against Lymphoma: The Verdict Is Reached

BH3 domains: intracellular death-ligands critical for initiating apoptosis

Antiangiogenic therapy and tumor progression

Antagonizing XIAP-mediated caspase-3 inhibition

Antagonism of Myc functions by Arf

An exciting forum for cancer research

Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes

A new anti-ErbB2 strategy in the treatment of cancer: Prevention of ligand-dependent ErbB2 receptor heterodimerization

A Malignant Oligarchy: Progenitors Govern the Behavior of Oligodendrogliomas

A dance between interferon-a/beta and p53 demonstrates collaborations in tumor suppression and antiviral activities

FAQs

Cancer Cell has an SJR of 19,027 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4704 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Cancer Cell is 16%.

Cancer Cell

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Cell?

What is the APC / publication cost?

What is the acceptance rate?